(Q44432219)

English

Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks

scientific article published on May 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks (English)

1 reference

Europe PubMed Central

2 December 2017

1 reference

10.1067/MJD.2003.103

https://api.crossref.org/works/10.1067/MJD.2003.103

31 December 2023

author name string

John Sefton

8

1 reference

Europe PubMed Central

2 December 2017

Tazarotene Cream Clinical Study Group

11

1 reference

Europe PubMed Central

2 December 2017

Gerald D. Weinstein

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734506

31 December 2023

John Y. M. Koo

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734506

31 December 2023

Gerald G. Krueger

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734506

31 December 2023

Mark G. Lebwohl

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734506

31 December 2023

Nicholas J. Lowe

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734506

31 December 2023

M. Alan Menter

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734506

31 December 2023

Deborah A. Lew-Kaya

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734506

31 December 2023

John R. Gibson

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734506

31 December 2023

Patricia S. Walker

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734506

31 December 2023

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

2 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0190962202615075?httpAccept=text/xml

1 reference

10.1067/MJD.2003.103

https://api.crossref.org/works/10.1067/MJD.2003.103

31 December 2023

https://api.elsevier.com/content/article/PII:S0190962202615075?httpAccept=text/plain

1 reference

10.1067/MJD.2003.103

https://api.crossref.org/works/10.1067/MJD.2003.103

31 December 2023

Journal of the American Academy of Dermatology

1 reference

Europe PubMed Central

2 December 2017

48

1 reference

Europe PubMed Central

2 December 2017

760-767

1 reference

Europe PubMed Central

2 December 2017

5

1 reference

Europe PubMed Central

2 December 2017

Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect

1

1 reference

10.1067/MJD.2003.103

https://api.crossref.org/works/10.1067/MJD.2003.103

31 December 2023

Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment for acne and psoriasis

2

1 reference

10.1067/MJD.2003.103

https://api.crossref.org/works/10.1067/MJD.2003.103

31 December 2023

Tazarotene--first of a new generation of receptor-selective retinoids.

3

1 reference

10.1067/MJD.2003.103

https://api.crossref.org/works/10.1067/MJD.2003.103

31 December 2023

Response of psoriasis to a new topical retinoid, AGN 190168

5

1 reference

10.1067/MJD.2003.103

https://api.crossref.org/works/10.1067/MJD.2003.103

31 December 2023

The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis

7

1 reference

10.1067/MJD.2003.103

https://api.crossref.org/works/10.1067/MJD.2003.103

31 December 2023

Assessing laboratory evidence for neoplastic activity

12

1 reference

10.1067/MJD.2003.103

https://api.crossref.org/works/10.1067/MJD.2003.103

31 December 2023

Comparative irritancy study among retinoid creams and gels

15

1 reference

10.1067/MJD.2003.103

https://api.crossref.org/works/10.1067/MJD.2003.103

31 December 2023

Identifiers

10.1067/MJD.2003.103

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44432219&oldid=2041143317"